Cangrelor in Acute Myocardial Infarction: Effectiveness and Outcomes Registry
NCT04076813 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 5050
Last updated 2025-06-13
Summary
The purpose of this registry is to address optimal platelet inhibition during the early management of MI patients prior to coronary angiography or CABG.
Conditions
Sponsors & Collaborators
- collaborator OTHER
-
Chiesi USA, Inc.
lead INDUSTRY
Principal Investigators
-
Jennifer Rymer, MD · Duke University
-
Jeffrey Washam · Duke University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-10-16
- Primary Completion
- 2025-06-30
- Completion
- 2025-06-30
Countries
- United States
Study Locations
More Related Trials
-
Cangrelor vs. Ticagrelor for Early Platelet Inhibition in STEMI
NCT03182855 ·Status: UNKNOWN ·Phase: PHASE4
-
Cangrelor Following Ticagrelor Loading vs Ticagrelor Loading Alone in STEMI
NCT02943369 ·Status: COMPLETED ·Phase: PHASE4
-
Antiplatelet Effects of Tirofiban vs. Cangrelor N-STEMI Patients Undergoing Percutaneous Coronary Intervention
NCT03048019 ·Status: TERMINATED
-
Safety and Efficacy of CMX-2043 for Protection of the Heart and Kidneys in Subjects Undergoing Coronary Angiography
NCT02103959 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacodynamic Effects of Cangrelor in ACS or CCS Patients Undergoing PCI (POMPEII Registry)
NCT04790032 ·Status: COMPLETED
-
Cangrelor in Comatose Survivors of OHCA Undergoing Primary PCI
NCT04005729 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of IV Cangrelor and Oral Ticagrelor Study
NCT02733341 ·Status: COMPLETED ·Phase: PHASE4
-
Dual Antiplatelet Therapy For Shock Patients With Acute Myocardial Infarction
NCT03551964 ·Status: COMPLETED ·Phase: PHASE4
-
Coronariography in OUt of hosPital Cardiac arrEst
NCT02641626 ·Status: COMPLETED ·Phase: NA
-
Early Versus Delayed Timing of Intervention in Patients With Acute Coronary Syndromes
NCT00552513 ·Status: COMPLETED ·Phase: NA
-
Barts-MINOCA Registry
NCT04440761 ·Status: RECRUITING
-
β Blocker Use and Mortality in Hospital Survivors of Acute Myocardial Infarction Without Heart Failure
NCT02786654 ·Status: COMPLETED
-
A Study Assessing the REG1 Anticoagulation System Compared Heparin in Subjects With Acute Coronary Syndrome
NCT00932100 ·Status: COMPLETED ·Phase: PHASE2
-
EMERGEncy Versus Delayed Coronary Angiogram in Survivors of Out-of-hospital Cardiac Arrest
NCT02876458 ·Status: COMPLETED ·Phase: NA
-
Randomized Comparison of Cangrelor, Tirofiban and Prasugrel in Patients With STEMI Referred for Primary PCI.
NCT02978040 ·Status: COMPLETED ·Phase: PHASE4
-
Platelet Inhibition to Target Reperfusion Injury
NCT03102723 ·Status: UNKNOWN ·Phase: PHASE2
-
Early Mineralocorticoid Receptor Antagonist Treatment to Reduce Myocardial Infarct Size
NCT01882179 ·Status: COMPLETED ·Phase: PHASE3
-
Very Early Versus Delayed Angiography +/- Intervention on Outcomes in Patients With NSTEMI
NCT03707314 ·Status: TERMINATED ·Phase: NA
-
Myocardial Ischemia and Transfusion
NCT02619136 ·Status: UNKNOWN ·Phase: NA
-
Coronary Angiography in Critically Ill Patients With Type II Myocardial Infarction
NCT04043091 ·Status: WITHDRAWN ·Phase: NA
-
Pilot Study on Shear-induced Platelet Aggregation in Acute Coronary Syndromes
NCT00299143 ·Status: COMPLETED
-
Cangrelor on Top of anticoagUlation in Patients With myocaRdial Infarction-related Cardiogenic Shock/Cardiac Arrest receiVIng VA-ECMO
NCT06792643 ·Status: RECRUITING ·Phase: PHASE2
-
Secondary Event Prevention Using Population Risk Management After PCI and for Anti-Rheumatic Medications
NCT02694185 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Feasibility and Safety Study Comparing REG1 Anticoagulation System With Unfractionated Heparin in Elective PCI
NCT00715455 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy Study of Combined Prasugrel and Bivalirudin Versus Clopidogrel and Heparin in Myocardial Infarction
NCT00976092 ·Status: UNKNOWN ·Phase: PHASE4